文振華，男，主任醫師，碩士，碩士生導師，中南大學湘雅3044永利集团附屬株洲醫院風濕免疫科主任，疑難罕見病中心副主任。 2007年6月七年制本碩連讀畢業于中南大學湘雅3044永利集团。研究興趣：1. 風濕免疫病及疑難罕見病的診治；2、臨床隊列研究；3、藥物經濟學研究。講授《臨床思維概述 》、《風濕免疫病概論》等課程。主持并完成湖南省自然科學青年基金項目1項，參與中華國際交流基金1項，以第一作者或通訊作者發表核心期刊論文20餘篇，作為主編和副主編出版專著兩部，2017年獲“中國風濕免疫科臨床實踐精英挑戰賽”全國總冠軍。
聯系方式：151728544@qq.com
代表性成果
1、Yu S, Deng L, Wang G, Li J, Wang J, Wen Z. Kimura's disease presenting as a posterior mediastinal mass complicated with relapsing polychondritis. Rheumatology (Oxford). 2022 Mar 2;61(3):e67-e68.
2、Chen LJ, Zhou YJ, Wen Z, Tian F, Li JY. Efficacy and safety of iguratimod combined with methotrexate vs. methotrexate alone in rheumatoid arthritis : A systematic review and meta-analysis of randomized controlled trials. Z Rheumatol. 2021 Jun;80(5):432-446.
3、Tian F, Wen Z（并列一作）, Li J, Luo X, Deng L, Zhang L, He J, Yao F, Liao Z. Cost-effectiveness of Anbainuo plus methotrexate compared to conventional disease-modifying antirheumatic drugs for rheumatoid arthritis patients in China. Ann Transl Med. 2021. Jul;9(14):1165.
4、Wang G, Zhuo N, Tian F, Wen Z. Spinal gout with erector spinae muscle entrapment. Rheumatology (Oxford). 2021 Jul 14:keab549. doi: 10.1093/rheumatology/keab549.
5、Wang G, Zhuo N, Tian F, Wen Z, Andersson lesion in the lumbar spine of SAPHO syndrome. Rheumatology (Oxford). 2021 May 11:keab417. doi: 10.1093/rheumatology/keab417.
6、Wang G, Zhuo N, Luo X, Tian F, Wen Z, IgG4-Related Disease With Testicular Involvement: A Case Report and Review of Literature. Front Immunol. 2021 Aug 10;12:717902.
7、Wang G, Zhuo N, Liao Z, Qi W, Tian F, Wen Z, Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report. Medicine (Baltimore). 2021 Jun 4;100(22):e25688.
8、Tian F, Li J , Wen Z , et al. A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients.[J]. Medicine, 2019, 98(48):e17750.
9、Li J , Wen Z , Cai A , et al. Real-world cost–effectiveness of infliximab for moderate-to-severe rheumatoid arthritis in a medium-sized city of China[J]. Journal of Comparative Effectiveness Research, 2017, 06(3):205-218.
10、文振華, 李敬揚, 蔣會平,等. 類風濕關節炎患者頸椎失穩的發生率及相關危險因素分析[J]. 中華風濕病學雜志, 2016, 20(5):5.
11、文振華, 李敬揚, 羅筱雯,等. 類風濕關節炎合并抑郁狀态的發生率及相關因素分析[J]. 中華風濕病學雜志, 2012, 16(2):4.
12、趙洪軍,文振華.等.臨床風濕免疫性疾病診療[M]. 吉林科學技術岀版社. 2019.
13、李敬揚, 文振華. 風濕病疑難病例解析[M]. 湖南科學技術出版社, 2013.
